Publisher: Research Institute for Gastroenterology and Liver Diseases (RIGLD)
  • Register
  • Login

Gastroenterology and Hepatology from Bed to Bench

  • Home
  • Issues
    • Current
    • Archives
  • About
    • About the Journal
    • Aims and Scope
    • Editorial Team
    • Privacy Statement
    • Contact
  • For Authors
    • Submissions
    • Author Guidelines
    • Peer Review Process
  • Indexing & Abstracting
  • Announcements
Advanced Search
  1. Home
  2. Archives
  3. Vol. 18 No. 3 (2025): Vol 18, No 3 (2025): Summer
  4. Editorial

Vol. 18 No. 3 (2025)

August 2025

The role of viruses and molecular markers in the diagnosis and treatment of cancers and rare diseases: challenges and perspectives

  • Amirhassan Rabbani
  • Nejat Mahdieh

Gastroenterology and Hepatology from Bed to Bench, Vol. 18 No. 3 (2025), 26 August 2025
https://doi.org/10.22037/ghfbb.v18i3.3198 Published: 2025-08-26

  • View Article
  • Download
  • Cite
  • References
  • Statastics
  • Share

Abstract

Common and rare diseases continue to impose a significant burden on healthcare systems worldwide. Viruses and molecular markers are increasingly recognized as pivotal in pathogenesis, early diagnosis, and the development of targeted therapies. Recent studies from Iran and other parts of the world have underscored the critical role of these factors in disease identification and management.

Keywords:
  • Oncogenic Viruses, Molecular Markers, Targeted Therapies
  • PDF

How to Cite

Rabbani, A., & Mahdieh, N. (2025). The role of viruses and molecular markers in the diagnosis and treatment of cancers and rare diseases: challenges and perspectives. Gastroenterology and Hepatology from Bed to Bench, 18(3). https://doi.org/10.22037/ghfbb.v18i3.3198
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

References

Sarshari B, Ravanshad M, Rabbani A, Zareh-Khoshchehreh R, Mokhtari F, Khanabadi B, et al. Quantitative analysis of Epstein-Barr virus DNA in plasma and stomach biopsies of patients with gastric cancer. Virus Genes 2023;59:351–8.

Hewavisenti RV, Arena J, Ahlenstiel CL, Sasson SC. Human papillomavirus in the setting of immunodeficiency: pathogenesis and the emergence of next-generation therapies to reduce the high associated cancer risk. Front Immunol 2023;14:1112513.

Fayazzadeh S, Ghorbaninejad M, Rabbani A, Zahiri J, Meyfour A. Predictive three-biomarker panel in peripheral blood mononuclear cells for detecting hepatocellular carcinoma. Sci Rep 2024;14:7527.

Wang L, Fatemi M, Alizad A. Artificial intelligence techniques in liver cancer. Front Oncol 2024;14:1415859.

Chavoshi V, Tamehri Zadeh SS, Khalili S, Rabbani A, Matini SAH, Mohsenifar Z, et al. Long delay in diagnosis of a case with MEN1 due to concomitant presence of AIMAH with insulinoma: a case report and literature review. BMC Endocr Disord 2022;22:108.

Asadzadeh Aghdaei H, Rabbani A, Sadeghi A, Rezvani H, Sherkat G, Salarieh N, et al. Retroperitoneal lymphangioma as the final diagnosis of a middle-aged woman with abdominal pain: a case report. J Med Case Rep 2023;17:93.

Rabbani B, Mahdieh N, Haghi Ashtiani MT, Akbari MT, Rabbani A. Molecular diagnosis of congenital adrenal hyperplasia in Iran: focusing on CYP21A2 gene. Iran J Pediatr 2011;21:139–50.

Mahdieh N, Mahmoudi H, Ahmadzadeh S, Bakhtiyari S. GJB2 mutations in deaf population of Ilam (Western Iran): a different pattern of mutation distribution. Eur Arch Otorhinolaryngol 2016;273:1161–5.

Edalat Zarei, Shafiekhani M, Azadeh N, Shamsaeefar A, Lotfi M, Ahrami M, et al. Passenger lymphocyte syndrome as a rare cause of hemolysis in a patient after small intestine transplantation: a case report and review of the literature. Asian J Transfus Sci 2022;16:135–9.

Fotros D, Sohouli M, Yari Z, Sakhdari H, Shafiekhani M, Nikoupour H, et al. Vitamin D status as a predictor for liver transplant outcomes. Sci Rep 2023;13:21018.

Shao W, Ding H, Wang Y, Shi Z, Zhang H, Meng F, et al. Key genes and immune pathways in T-cell mediated rejection post-liver transplantation identified via integrated RNA-seq and machine learning. Sci Rep 2024;14:24315.

  • Abstract Viewed: 158 times
  • PDF Downloaded: 52 times

Download Statastics

  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram

Developed By

Open Journal Systems
  • Home
  • Archives
  • Submissions
  • About the Journal
  • Editorial Team
  • Contact

GHFBB journal is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Print ISSN: 2008-2258
Online ISSN: 2008-4234

Support Contact: ghfbb.journal@gmail.com

 

GHFBB is an open-access journal and does not charge fees for authors who submit their articles and for readers who access PDF files of published articles.

Powered by OJSPlus